School of Engineering
Pharmaceutical Chemistry Group
The research focuses on two main areas: New Drugs in Biomedicine and Health Sciences and Flow Chemistry Processes.
TKI inhibitors for lypmhoma therapies
Dr Victor Masip recently defended his doctoral thesis at IQS, in which he designed, synthesized, and characterized potential new inhibitors of the ZAP-70 protein for peripheral T lymphoma therapies.READ FULL NEW
7 Questions for...
Dr. Albert Gibert, Profesor de IQS School of Engineering e investigador del Grupo de Química Farmacéutica.READ FULL NEW